U.S., Jan. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07378644) titled 'Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's Disease' on Jan. 13.
Brief Summary: The goal of this clinical trial is to test if the drug SKY-0515, an oral medication, can lower harmful proteins linked to Huntington's Disease (HD) and improve the symptoms of participants with HD. This study includes men and women aged 25 and older who have HD confirmed by genetic testing and meet certain requirements for physical ability and independence.
Study Start Date: Jan. 06
Study Type: INTERVENTIONAL
Condition:
Huntington Disease
Intervention:
DRUG: SKY-0515
Type: Small molecul...